3Bridger T,MacDonald S,Baltzer F,et al.Randomized placebo-controlled trial of metformin for adolescents with polycystic ovary syndrome[J].Arch Pediatr Adolesc Med,2006,160(3):241-246.
4Sahin I,Serter R,Karakurt F,et al.Metformin versus flutamide in the treatment of metabolic consequences of non-obese young women with polycystic ovary syndrome:a randomized prospective study[J].Gynecol Endocrinol,2004,19 (3):115-124.
5Eisenhart S,Schwarzmann N.Early effects of metformin in women with polycystic ovary syndrome:a prospective randomized,double-blind,placebo-controlled trial[J].J Clin Endocrinol Metab,2006,91:946-952.
6Antonio LM,Alfredo CA,Gaspare S,et al.Metformin treatment of PCOS during adolescence and the reproductive period[J].Eur J Obstet Gynecol Reprod Biol,2005,121 (1):3-7.
7Lehmann JM,Moore LB,Smith-Oliver TA,et al.An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor-γ[J].J Biol Chem,1995,270 (22):12953-12956.
8Garmes HM,Tambascia MA,Zantut-Wittmann DE.Endocrinometabolic effects of the treatment with pioglitazone in obese patients with polycystic ovary syndrome[J].Gynecol Endocrinol,2005,21 (6):317-323.
9Ortega-Gonzalez C,Luna S,Hernandez L,et al.Responses of serum androgen and insulin resistance to metformin and pioglitazone in obese,insulin-resistant women with polycystic ovary syndrome[J].J Clin Endocrinol Metab,2005,90 (3):1360-1365.
10Glueck CJ,Moreira A,Goldenberg N,et al.Pioglitazone and metformin in obese women with polycystic ovary syndrome not optimally responsive to metformin[J].Hum Reprod,2003,18(8):1618-1625.
